Summary : The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Severe
-
-
Synopsis: The FDA’s authorization expands the drug’s use to fight Covid-19 to people under the age of 12 The therapy, Bamlanivimab plus…
-
Mepolizumab
GlaxoSmithKline`s Nucala (Mepolizumab) gets European Approval for use in Three Additional Eosinophil-driven Diseases.
by adminby adminKEYPOINTS: GlaxoSmithKline (NYSE:GSK) announces that the European Commission has approved Nucala (Mepolizumab), a monoclonal antibody that targets interleukin-5, for use in three…